TAL vs UTI: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
TAL and UTI are similarly sized, but TAL trades noticeably cheaper on forward earnings (11.53x vs 42.27x): the market is paying up for UTI's profile and pricing TAL more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
TAL vs UTI: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | TAL | UTI | What it tells you |
|---|---|---|---|
| Forward P/E | 11.53 | 42.27 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 7.81 | 51.72 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.07 | 1.23 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 81% of range | 60% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.83 | 6.37 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: TAL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how TAL and UTI affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. TAL and UTI share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined TAL and UTI exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does TAL Education Group (TAL) do?
TAL Education Group is a China-based education and technology company that provides learning services and sells AI-powered learning devices and tablets, largely under its Xueersi and Think Academy brands. Its business today is very different from the one investors knew before 2021. China's July 2021 double reduction policy banned for-profit tutoring in core academic K-12 subjects, which had accounted for more than 80% of TAL's revenue, and the stock lost roughly 90% of its value as the company shut down its curriculum-based tutoring operations. Since then TAL has rebuilt around non-academic enrichment programs, content solutions, and a growing hardware line, including learning devices such as the P4, S4, and T4 models and the TalPad T100 AI tutoring tablet, with embedded AI companions like Thinkie designed to guide learners step by step.
What does Universal Technical Institute (UTI) do?
Universal Technical Institute, Inc. (NYSE: UTI) runs postsecondary vocational schools across two reportable segments. The legacy UTI segment trains students in automotive, diesel, motorcycle, marine, welding, CNC and related skilled trades, while the Concorde Career Colleges segment (acquired in 2022) offers allied health, dental, nursing, patient-care and diagnostic programs. The company generates revenue primarily from student tuition, much of it funded through federal Title IV financial aid, and it has been growing student starts and average full-time enrollment at both segments.
TAL vs UTI: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- TAL drivers: Learning-device and AI hardware growth; Rebuilt non-academic learning services.
- UTI drivers: Skilled-trades demand tailwind; Concorde and healthcare diversification.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risks are specific to Chinese ADRs. For UTI, uTI depends heavily on federal Title IV student aid, so changes to financial-aid rules, gainful-employment regulations, or the 90/10 revenue rule could materially affect the business.
TAL or UTI: which should you pick?
TAL vs UTI: the full fundamentals
TAL. Figures are approximate and tied to the asOf date; verify live numbers before acting. TAL is valued as much on China policy and geopolitics as on its financials, so standard earnings multiples can be misleading. The recovery in revenue and the return to profitability are the clearest positives, but a China ADR trades with a persistent regulatory and delisting discount that can compress or expand quickly on political news rather than on business results.
UTI. Fiscal 2025 revenue grew about 14% and net income rose roughly 50% to about $63 million. Fiscal 2026 guidance calls for revenue near $905 to $915 million but net income of only about $40 to $45 million, reflecting roughly $40 million of growth-investment spending. The premium P/E reflects investor expectations that campus expansion will lift future earnings.
Headline figures (approximate, Jul 2026): TAL shows revenue trend Strong double-digit growth: approximately US$575 million in fiscal Q1 2026, up about 39% year over year, and roughly US$770 million in fiscal Q3 2026, up about 27% year over year, profitability Returned to profitability, with positive net income attributable to shareholders in recent quarters (about US$131 million reported in fiscal Q3 2026) after prior operating losses, business mix Learning services plus a fast-growing AI learning-device and tablet line (Think Academy), a very different mix from the pre-2021 academic tutoring model, capital return Announced a share buyback program of up to approximately US$600 million; UTI shows revenue (fy2025) ~$835.6M, revenue guidance (fy2026) ~$905-915M, net income (fy2025) ~$63M, adjusted ebitda (fy2025) ~$126.5M.
The bottom line: TAL vs UTI
TAL and UTI are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined TAL and UTI exposure against your real portfolio. It is not an investment adviser.
Wondering how TAL or UTI fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in TAL Education Group with AI
Connect the broker you already use and ask Walnut's AI how TAL fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between TAL and UTI?
+
TAL Education Group is a China-based education and technology company that provides learning services and sells AI-powered learning devices and tablets, largely under its Xueersi and Think Academy brands. Universal Technical Institute, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is TAL or UTI the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, TAL or UTI?
+
On forward P/E (as of August 2026), TAL trades at 11.53x and UTI at 42.27x, so TAL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both TAL and UTI?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of TAL vs UTI?
+
TAL: The dominant risks are specific to Chinese ADRs. TAL operates through a variable interest entity (VIE) structure, meaning US investors own shares in an offshore holding company that contracts with the China operating entities rather than owning those entities directly, a structure Chinese authorities have never fully endorsed. Regulatory risk is real and proven: the 2021 double reduction policy erased most of TAL's revenue and value almost overnight, and renewed tightening of education, data, or foreign-investment rules could happen again with little warning. US-China tensions add delisting and audit risk under the Holding Foreign Companies Accountable Act, even though TAL currently complies with PCAOB rules. Beyond policy, the turnaround itself can stall: the non-academic and device markets are more competitive and lower-margin than the old tutoring business, and rivals such as New Oriental are pursuing similar pivots. Currency swings between the renminbi and US dollar, and the general opacity of China-based reporting, round out the risk profile. UTI: UTI depends heavily on federal Title IV student aid, so changes to financial-aid rules, gainful-employment regulations, or the 90/10 revenue rule could materially affect the business. Near-term profitability has already collapsed on expansion spending, and the stock's premium multiple leaves little room for disappointment if new campuses underperform or enrollment growth stalls. The for-profit education sector carries a history of regulatory scrutiny and reputational risk. Rising labor and real-estate costs can pressure margins, and an economic downturn can cut both ways on enrollment. Any softening in student starts or graduate placement rates would challenge the growth narrative underpinning the current valuation.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell TAL or UTI; figures are approximate and dated (as of August 2026). Verify current data before investing.